The Prognosis of Myeloma and Macroglobulinemia

  • Jan G. Waldenström
Conference paper


One of the most interesting problems in modern mediane is whether survival of patients with solitary solid tumors (cancers) and with systemic diseases, such as leukemia, lymphoma, and plasmocytoma, is really prolonged by modern treatment with cytostatic drugs. The number of solid tumors that are healed with such treatment is very low, and it must still be acknowledged that we have much to learn and hope for in this fleld. Regarding systemic diseases, the goal should be what has been called “eradication of the last cell”. Hodgkin’s disease, when treated with irradiation, in favorable cases sometimes combined with cytostatic drugs, is definitely healed. Non-Hodgkin lymphoma is much more difficult to treat with lasting success, if we except Burkitt’s lymphoma that has a some-what special position.


Multiple Myeloma Acute Leukemia Cytostatic Drug Cold Agglutinin Chronic Leukemia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Springer-Verlag Berlin · Heidelberg 1980

Authors and Affiliations

  • Jan G. Waldenström

There are no affiliations available

Personalised recommendations